AI news that drew views this week (March 15–19)

Affronts against privacy and equality—real, perceived or ginned up—may fuel lawsuits by patients whose COVID care incorporated AI.

The FDA has cleared an AI tool that helps radiologists diagnose or rule out prostate cancer on MRI scans.

The advance represents the first cancer-care pathway offering an automatically combined analysis of morphological, molecular and histological data. 

A new survey of around 300 youngish parents has found almost two-thirds worried they’re spending so much time distracted by electronic devices that their children’s development may be at risk.

Does Big Blue’s toe in the water say more about IBM in particular than it says about healthcare AI in general?

Virtual reality can help quell perceptions of pain as well as dampening the prickling sensations that patients with nerve damage sometimes experience upon being touched.

Researchers have developed an AI-based system that can direct the administering of iron and other red-blood-cell stimulators nearly as well as experienced physicians.

The European Union has granted CE mark approval to a U.S.-based maker of AI software that aids radiologists in distinguishing between benign and malignant lesions on breast ultrasound images.